Boehringer Ingelheim is a privately held pharmaceutical company that develops and manufactures prescription medicines for human healthcare, including therapies in areas such as cardiovascular, respiratory, metabolic, immunology and oncology. It also provides animal-health medicines and vaccines through its Boehringer Ingelheim Animal Health business, serving healthcare professionals, patients and veterinary customers worldwide.
Subscribe to see Boehringer Ingelheim’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of Boehringer Ingelheim's closest competitors — see the full list of competitors and alternatives →
Orion Oyj is a pharmaceutical and healthcare company that develops, manufactures, and markets medicines, self-care products, active pharmaceutical ingredients, and animal health products. The company serves patients, healthcare professionals, and the veterinary sector globally with treatments focused on therapy areas such as oncology, respiratory diseases, and neurology.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
DEVA Holding is a pharmaceutical company that develops and manufactures human and veterinary medicines, active pharmaceutical ingredients, and healthcare solutions.
Krka is a multinational generic pharmaceutical company that develops, produces, and markets prescription pharmaceuticals, non-prescription products, and animal health products.
União Química Farmacêutica Nacional S.A. is a Brazilian pharmaceutical manufacturer that develops and produces medicines for human healthcare, including prescription, over-the-counter, and hospital products. It also operates in animal health and serves pharmacies, hospitals, healthcare providers, and veterinary markets in Brazil and other countries.
Orion Pharma is a globally operating Nordic pharmaceutical company headquartered in Espoo, Finland. The company focuses on building well-being and sells its products in over a hundred countries worldwide, including through its Animal Health offices in Turku.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.